BlueYard Capital
Edit

BlueYard Capital

https://www.blueyard.com
Last activity: 24.10.2025
Active
BlueYard backs founders building the interconnected elements that can become the fabric of our future.
Portfolio
7
Mentions
45
Investment Type: Venture Capital

Portfolio 7

DateNameWebsiteTotal RaisedLocation
06.10.2025Aerskaaerska.com$21MIreland
26.09.2025Corintis S...corintis.com$24MSwitzerlan...
18.07.2023Tromero Lt...tromero.org$2MUnited Kin...
17.07.2023Rapidatarapidata.ai$1.75MSwitzerlan...
06.04.2023Sensible B...sensible.bio$4.2MUnited Kin...
11.01.2023Visolisvisolisbio.com$8MUnited Sta...
07.04.2016deepstream...deepstreamhub.com$1MGermany, B...

Mentions in press and media 45

DateTitleDescription
24.10.2025+++ Pitch it! +++ Formel Skin +++ Manual +++ BlueYard Capital +++ Michael Wax +++ Hello Inside +++Was gibt’s Neues? In unserem #StartupTicker liefern wir eine kompakte Übersicht über die wichtigsten Startup-Nachrichten des Tages (Freitag, 24. Oktober). #STARTUPLAND SAVE THE DATE: Am 5. November findet unsere zweite STARTUPLAND statt. Au...
22.10.2025Chemify Raises $50M in Series B FundingGlasgow spin-out Chemify has secured more than $50 million in series B funding. The funding round, which was oversubscribed, was co-led by Wing Venture Capital and Insight Partners, with further participation from 8VC and existing backers E...
22.10.2025Chemify Raises Over $50M in Series B FundingChemify, a Glasgow, Scotland, UK-based deep-tech company combining chemistry, robotics, computation, and AI to digitize molecule creation, raised over $50m in Series B funding. The round was co-led by Wing Venture Capital and Insight Partne...
22.10.2025Chemify: Over $50 Million Series B Raised To Expand Global Network of Digital Chemistry FacilitiesChemify, a company pioneering the fusion of chemistry, robotics, computation, and artificial intelligence, announced it has raised more than $50 million in an oversubscribed Series B funding round. The financing was co-led by Wing Venture C...
06.10.2025Aerska Secures $21M to Transform Neurological Disease Treatment with RNAiDublin-based biotech Aerska raised $21 million in seed financing. This significant capital boost targets groundbreaking RNA interference (RNAi) medicines. The company aims to redefine neurological disease treatment. Aerska employs innovativ...
06.10.2025Aerska Raises $21M in Seed FinancingAerska, a Dublin, Ireland-based biotechnology company improving the treatment of neurological diseases, raised $21M in seed financing. The round was co-led by Age1, Backed VC and Speedinvest, with participation from Blueyard, Lingotto (Exor...
03.10.2025Europe's Tech Divide: New Funds Emerge as Startups Face Insolvency and LossesEurope's startup ecosystem sees major movements. The Global Resilience Innovation Fund (GRIF) debuts, targeting €250M for DefenseTech and security innovations across NATO states. Norwegian private equity firm Verdane secures €2 billion for ...
01.10.2025Irish biotech Aerska raises $21m to tackle neurological diseasesIrish biotech start-up Aerska has raised $21m (€19.5m) in seed funding to advance new genetic medicines aimed at treating and preventing neurological diseases such as Alzheimer’s and Parkinson’s. The company, founded by Irish entrepreneur J...
01.10.2025+++ Global Resilience Innovation Fund +++ Next Matter +++ Luca +++ suena energy +++ VerdaneWas gibt’s Neues? In unserem #StartupTicker liefern wir eine kompakte Übersicht über die wichtigsten Startup-Nachrichten des Tages (Mittwoch, 1. Oktober). #STARTUPLAND SAVE THE DATE: Am 5. November findet unsere zweite STARTUPLAND statt. Es...
01.10.2025Irish BioTech Aerska launches with €17 million to develop RNAi medicines for diseases of the brainAerska, a Dublin-based BioTech company aiming to redefine the treatment of neurological diseases, today announced it has raised €17 million in Seed financing to develop systemically administered RNA interference (RNAi) medicines designed to...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In